Myriad Genetics
This article was originally published in The Gray Sheet
Executive Summary
People with a high hereditary susceptibility for breast and ovarian cancer and who receive insurance coverage under Aetna U.S. Healthcare will have access to Myriad's BRACAnalysis breast and ovarian susceptibility tests under a multi-year agreement announced Aug. 3